The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Urine cystatin C (uCyC) as a predictor for acute kidney injury (AKI) in urothelial cancer (UC) patients (pts) treated with cisplatin (CDDP).
 
Michael J Jelinek
No Relationships to Disclose
 
Alicia J Wyche
No Relationships to Disclose
 
Claudia Wing
No Relationships to Disclose
 
Jay L Koyner
Consulting or Advisory Role - Astute; Pfizer
Research Funding - NxStage; Satellite Healthcare
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Dendreon; Johnson & Johnson; medpacto; Merck; Millennium; Novartis; Roche/Genentech; Veridex
Consulting or Advisory Role - Bayer; CVS Caremark; Dendreon; Genentech/Roche; Medivation; medpacto; Millennium; Novartis; Sotio; Veridex
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - UpToDate
 
Patrick T Murray
No Relationships to Disclose
 
Peter H. O'Donnell
Stock and Other Ownership Interests - DaVita
Honoraria - American Medical Forum; Indiana University; OptumHealth; University of Florida
Consulting or Advisory Role - Abbott Molecular; Advance Medical; Algeta ASA; Dendreon
Patents, Royalties, Other Intellectual Property - Genomic Prescribing System
Travel, Accommodations, Expenses - Sequenom